Literature DB >> 22039555

Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli ulcer.

Claire L Gordon1, John A Buntine, John A Hayman, Caroline J Lavender, Janet A Fyfe, Patrick Hosking, Paul D R Johnson.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22039555      PMCID: PMC3201911          DOI: 10.1371/journal.pntd.0001290

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


× No keyword cloud information.
  20 in total

Review 1.  Mycobacterium ulcerans infection: control, diagnosis, and treatment.

Authors:  Vinciane Sizaire; Fabienne Nackers; Eric Comte; Françoise Portaels
Journal:  Lancet Infect Dis       Date:  2006-05       Impact factor: 25.071

2.  Homologous and heterologous immunity in infections of mice with Mycobacterium ulcerans and Mycobacterium balnei.

Authors:  F FENNER
Journal:  Am Rev Tuberc       Date:  1957-07

3.  Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.

Authors:  Y Stienstra; T S van der Werf; E Oosterom; I M Nolte; W T A van der Graaf; S Etuaful; P L Raghunathan; E A S Whitney; E O Ampadu; K Asamoa; E Y Klutse; G J te Meerman; J W Tappero; D A Ashford; G van der Steege
Journal:  Genes Immun       Date:  2006-04       Impact factor: 2.676

4.  Buruli ulcer.

Authors:  Mark Wansbrough-Jones; Richard Phillips
Journal:  BMJ       Date:  2005-06-18

5.  A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine.

Authors:  W D Revill; R H Morrow; M C Pike; J Ateng
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

Review 6.  Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection.

Authors:  J Hayman
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

Review 7.  Mycobacterium ulcerans disease.

Authors:  Tjip S van der Werf; Ymkje Stienstra; R Christian Johnson; Richard Phillips; Ohene Adjei; Bernhard Fleischer; Mark H Wansbrough-Jones; Paul D R Johnson; Françoise Portaels; Winette T A van der Graaf; Kingsley Asiedu
Journal:  Bull World Health Organ       Date:  2005-11-10       Impact factor: 9.408

8.  Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts.

Authors:  Travis M Gooding; Paul D R Johnson; May Smith; Andrew S Kemp; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  All-oral antibiotic treatment for buruli ulcer: a report of four patients.

Authors:  Claire L Gordon; John A Buntine; John A Hayman; Caroline J Lavender; Janet A M Fyfe; Patrick Hosking; Mike Starr; Paul D R Johnson
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

10.  Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.

Authors:  Paul D R Johnson; Timothy Stinear; Pamela L C Small; Gerd Pluschke; Richard W Merritt; Francoise Portaels; Kris Huygen; John A Hayman; Kingsley Asiedu
Journal:  PLoS Med       Date:  2005-04-26       Impact factor: 11.069

View more
  16 in total

Review 1.  The chemistry and biology of mycolactones.

Authors:  Matthias Gehringer; Karl-Heinz Altmann
Journal:  Beilstein J Org Chem       Date:  2017-08-11       Impact factor: 2.883

2.  Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?

Authors:  Raquel Cowan; Eugene Athan; N Deborah Friedman; Andrew J Hughes; Anthony McDonald; Peter Callan; Janet Fyfe; Daniel P O'Brien
Journal:  PLoS Negl Trop Dis       Date:  2015-02-06

3.  Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.

Authors:  Miriam Bolz; Sarah Kerber; Gert Zimmer; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2015-08-14

4.  Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.

Authors:  Paul J Converse; Sandeep Tyagi; Yalan Xing; Si-Yang Li; Yoshito Kishi; John Adamson; Eric L Nuermberger; Jacques H Grosset
Journal:  PLoS Negl Trop Dis       Date:  2015-06-04

5.  Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.

Authors:  Raphael Bieri; Miriam Bolz; Marie-Thérèse Ruf; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2016-02-10

Review 6.  Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).

Authors:  Rie R Yotsu; Marty Richardson; Norihisa Ishii
Journal:  Cochrane Database Syst Rev       Date:  2018-08-23

7.  Comparison of two assays for molecular determination of rifampin resistance in clinical samples from patients with Buruli ulcer disease.

Authors:  Moritz Jansson; Marcus Beissner; Richard Odame Phillips; Kossi Badziklou; Ebekalisai Piten; Issaka Maman; Fred Stephen Sarfo; Kristina Lydia Huber; Agata Rhomberg; Dominik Symank; Magdalena Wagner; Franz Wiedemann; Jörg Nitschke; Abiba Banla Kere; Karl-Heinz Herbinger; Ohene Adjei; Thomas Löscher; Gisela Bretzel
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

8.  Spontaneous clearance of a secondary Buruli ulcer lesion emerging ten months after completion of chemotherapy--a case report from Togo.

Authors:  Marcus Beissner; Ebekalisai Piten; Issaka Maman; Dominik Symank; Moritz Jansson; Jörg Nitschke; Komi Amekuse; Basil Kobara; Franz Wiedemann; Harald Hoffmann; Adolf Diefenhardt; Kossi Badziklou; Abiba Banla Kere; Thomas Löscher; Gisela Bretzel
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31

9.  Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.

Authors:  Miriam Bolz; Angèle Bénard; Anita M Dreyer; Sarah Kerber; Andrea Vettiger; Wulf Oehlmann; Mahavir Singh; Malcolm S Duthie; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2016-02-05

10.  Complete Healing of a Laboratory-Confirmed Buruli Ulcer Lesion after Receiving Only Herbal Household Remedies.

Authors:  Arianna Andreoli; Ferdinand Mou; Jacques C Minyem; Fidèle G Wantong; Djeunga Noumen; Paschal K Awah; Gerd Pluschke; Alphonse Um Boock; Martin W Bratschi
Journal:  PLoS Negl Trop Dis       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.